Please join us to review the first year of operation of Europe’s Unified Patent Court. We will address issues in life sciences and high-tech.
Our panelists from Germany, France, Ireland, the UK and the US will give their own national perspectives on how the UPC is shaping up. We will review the leading decisions coming out of the UPC, and identify trend lines to help navigate this important new forum. Not surprisingly, they don’t all share the same views.
Key questions that our global panel will address include:
- What differences can parties expect between different countries?
- Is the UPC a “pro patent” court? Does that answer vary based on country?
- How are litigants exploiting the tensions between UPC’s Local Divisions and its Central Division?
- Will the court grant preliminary injunctions and does the chance vary by country?
- Will evidentiary seizures proliferate, and if so, where and why?
- What types of damages are being awarded?
- How is the UPC approaching SEPs and FRAND issues?
- What alternatives to the UPC should be considered and why?